tetano
Editor, Senior Moderator
BMC Ophthalmol
. 2023 May 24;23(1):233.
doi: 10.1186/s12886-023-02978-2. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination
Yo Ogino[SUP] 1 [/SUP], Kenichi Namba[SUP] 2 [/SUP], Daiju Iwata[SUP] 1 [/SUP], Kayo Suzuki[SUP] 1 [/SUP], Kazuomi Mizuuchi[SUP] 1 [/SUP], Miki Hiraoka[SUP] 3 [/SUP], Nobuyoshi Kitaichi[SUP] 3 [/SUP], Susumu Ishida[SUP] 1 [/SUP]
Affiliations
Background: Vaccination against the worldwide pandemic coronavirus disease 2019 (COVID-19) is underway; however, some cases of new onset uveitis after vaccination have been reported. We report a case of bilateral acute posterior multifocal placoid pigment epitheliopathy-like (AMPPE-like) panuveitis after COVID-19 vaccination in which the patient's pathological condition was evaluated using multimodal imaging.
Case presentation: A 31-year-old woman experienced bilateral hyperemia and blurred vision starting 6 days after her second inoculation of the COVID-19 vaccination. At her first visit, her visual acuity was decreased bilaterally, and severe bilateral anterior chamber inflammation and bilateral scattering of cream-white placoid lesions on the fundus were detected. Optical coherence tomography (OCT) showed serous retinal detachment (SRD) and choroidal thickening in both eyes (OU). Fluorescein angiography (FA) revealed hypofluorescence in the early phase and hyperfluorescence in the late phase corresponding to the placoid legions. Indocyanine green angiography (ICGA) showed sharply marginated hypofluorescent dots of various sizes throughout the mid-venous and late phases OU. The patient was diagnosed with APMPPE and was observed without any medications. Three days later, her SRD disappeared spontaneously. However, her anterior chamber inflammation continued, and oral prednisolone (PSL) was given to her. Seven days after the patient's first visit, the hyperfluorescent lesions on FA and hypofluorescent dots on ICGA partially improved; however, the patient's best corrected visual acuity (BCVA) recovered only to 0.7 OD and 0.6 OS, and the impairment of the outer retinal layer was broadly detected as hyperautofluorescent lesions on fundus autofluorescence (FAF) examination and as irregularity in or disappearance of the ellipsoid and interdigitation zones on OCT, which were quite atypical for the findings of APMPPE. Steroid pulse therapy was performed. Five days later, the hyperfluorescence on FAF had disappeared, and the outer retinal layer improved on OCT. Moreover, the patient's BCVA recovered to 1.0 OU. Twelve months after the end of treatment, the patient did not show any recurrences.
Conclusions: We observed a case of APMPPE-like panuveitis after COVID-19 vaccination featuring some atypical findings for APMPPE. COVID-19 vaccination may induce not only known uveitis but also atypical uveitis, and appropriate treatment is required for each case.
Keywords: Acute posterior multifocal placoid pigment epitheliopathy; COVID-19 vaccination; Multimodal imagings; Steroid pulse treatment.
. 2023 May 24;23(1):233.
doi: 10.1186/s12886-023-02978-2. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination
Yo Ogino[SUP] 1 [/SUP], Kenichi Namba[SUP] 2 [/SUP], Daiju Iwata[SUP] 1 [/SUP], Kayo Suzuki[SUP] 1 [/SUP], Kazuomi Mizuuchi[SUP] 1 [/SUP], Miki Hiraoka[SUP] 3 [/SUP], Nobuyoshi Kitaichi[SUP] 3 [/SUP], Susumu Ishida[SUP] 1 [/SUP]
Affiliations
- PMID: 37226110
- DOI: 10.1186/s12886-023-02978-2
Background: Vaccination against the worldwide pandemic coronavirus disease 2019 (COVID-19) is underway; however, some cases of new onset uveitis after vaccination have been reported. We report a case of bilateral acute posterior multifocal placoid pigment epitheliopathy-like (AMPPE-like) panuveitis after COVID-19 vaccination in which the patient's pathological condition was evaluated using multimodal imaging.
Case presentation: A 31-year-old woman experienced bilateral hyperemia and blurred vision starting 6 days after her second inoculation of the COVID-19 vaccination. At her first visit, her visual acuity was decreased bilaterally, and severe bilateral anterior chamber inflammation and bilateral scattering of cream-white placoid lesions on the fundus were detected. Optical coherence tomography (OCT) showed serous retinal detachment (SRD) and choroidal thickening in both eyes (OU). Fluorescein angiography (FA) revealed hypofluorescence in the early phase and hyperfluorescence in the late phase corresponding to the placoid legions. Indocyanine green angiography (ICGA) showed sharply marginated hypofluorescent dots of various sizes throughout the mid-venous and late phases OU. The patient was diagnosed with APMPPE and was observed without any medications. Three days later, her SRD disappeared spontaneously. However, her anterior chamber inflammation continued, and oral prednisolone (PSL) was given to her. Seven days after the patient's first visit, the hyperfluorescent lesions on FA and hypofluorescent dots on ICGA partially improved; however, the patient's best corrected visual acuity (BCVA) recovered only to 0.7 OD and 0.6 OS, and the impairment of the outer retinal layer was broadly detected as hyperautofluorescent lesions on fundus autofluorescence (FAF) examination and as irregularity in or disappearance of the ellipsoid and interdigitation zones on OCT, which were quite atypical for the findings of APMPPE. Steroid pulse therapy was performed. Five days later, the hyperfluorescence on FAF had disappeared, and the outer retinal layer improved on OCT. Moreover, the patient's BCVA recovered to 1.0 OU. Twelve months after the end of treatment, the patient did not show any recurrences.
Conclusions: We observed a case of APMPPE-like panuveitis after COVID-19 vaccination featuring some atypical findings for APMPPE. COVID-19 vaccination may induce not only known uveitis but also atypical uveitis, and appropriate treatment is required for each case.
Keywords: Acute posterior multifocal placoid pigment epitheliopathy; COVID-19 vaccination; Multimodal imagings; Steroid pulse treatment.